Panobinostat, Lenalidomide, Bortezomib + Dexamethasone in Relapsed and Relapsed/Refractory Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Cancer Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 1 Open-Label Study of Panobinostat, Lenalidomide, Bortezomib + Dexamethasone in Relapsed and Relapsed/Refractory Multiple Myeloma
Blood Cancer J 2021 Feb 05;[EPub Ahead of Print], JP Laubach, SA Tuchman, JM Rosenblatt, CS Mitsiades, K Colson, K Masone, D Warren, RA Redd, D Grayson, PG RichardsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.